Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 4Glioblastoma 3Esophageal Neoplasms 3Recurrence 2Esophageal Squamous Cell Carcinoma 2Endometrial Neoplasms 2Brain Neoplasms 2Thyroid Neoplasms 1Pathologic Complete Response 1Oligodendroglioma 1Lymphoma, Follicular 1Lymphatic Metastasis 1Li-Fraumeni Syndrome 1Gliosarcoma 1Glioma 1Ependymoma 1Disease 1DWI-MRI 1Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Astrocytoma 1Adenocarcinoma Of Esophagus 1

Interventions

Iodine-131 14trametinib 9dabrafenib 9Thyroidectomy 9Surgical Procedures, Operative 9lenvatinib 8Thyroxine 8Magnetic Resonance Spectroscopy 8pembrolizumab 7Paclitaxel 7anlotinib 6Thyrotropin Alfa 6selpercatinib 5Sorafenib 5Saline Solution 5Radiofrequency Ablation 5Everolimus 5pazopanib 4Vemurafenib 4Sunitinib 4Radiotherapy 4Nivolumab 4Fluorodeoxyglucose F18 4Dexmedetomidine 4Cyclophosphamide 4Biopsy, Fine-Needle 4Biopsy 4Bevacizumab 4apatinib 3Triiodothyronine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thyroid Neoplasms × Diffusion Magnetic Resonance Imaging × Clear all
NCT01882816 2022-12-29

Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
27 enrolled 12 charts
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡